Summary
Avience Biomedicals Limited is launching its SME IPO worth ₹30.24 crore. The company operates in the biotechnology, genomics, and IVD diagnostics industry and offers a wide range of molecular diagnostic products, rapid test kits, analyzers, and medical equipment. With healthy profitability, strong return ratios, and expanding operations, the IPO has attracted investor attention. As of...
SPARK Website
English